Ancora Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $67.5K | Sell |
241
-266
| -52% | -$69.9K | ﹤0.01% | 991 |
|
|
2026
Q1 | $135K | Buy |
507
+95
| +23% | +$25.7K | ﹤0.01% | 825 |
|
|
2025
Q4 | $103K | Buy |
412
+170
| +70% | +$45.1K | ﹤0.01% | 902 |
|
|
2025
Q3 | $69.5K | Hold |
242
| – | – | ﹤0.01% | 959 |
|
|
2025
Q2 | $63.5K | Hold |
242
| – | – | ﹤0.01% | 974 |
|
|
2025
Q1 | $56.3K | Sell |
242
-8
| -3% | -$1.94K | ﹤0.01% | 993 |
|
|
2024
Q4 | $57.3K | Buy |
250
+8
| +3% | +$1.83K | ﹤0.01% | 974 |
|
|
2024
Q3 | $54.1K | Sell |
242
-86
| -26% | -$18.9K | ﹤0.01% | 970 |
|
|
2024
Q2 | $66.8K | Hold |
328
| – | – | ﹤0.01% | 888 |
|
|
2024
Q1 | $71.7K | Hold |
328
| – | – | ﹤0.01% | 873 |
|
|
2023
Q4 | $74.6K | Sell |
328
-233
| -42% | -$48.9K | ﹤0.01% | 858 |
|
|
2023
Q3 | $113K | Sell |
561
-92
| -14% | -$19.4K | ﹤0.01% | 765 |
|
|
2023
Q2 | $135K | Hold |
653
| – | – | ﹤0.01% | 729 |
|
|
2023
Q1 | $129K | Hold |
653
| – | – | ﹤0.01% | 730 |
|
|
2022
Q4 | $132K | Hold |
653
| – | – | ﹤0.01% | 768 |
|
|
2022
Q3 | $115K | Hold |
653
| – | – | ﹤0.01% | 858 |
|
|
2022
Q2 | $131K | Hold |
653
| – | – | ﹤0.01% | 878 |
|
|
2022
Q1 | $148K | Sell |
653
-81
| -11% | -$19.1K | ﹤0.01% | 897 |
|
|
2021
Q4 | $198K | Hold |
734
| – | – | ﹤0.01% | 811 |
|
|
2021
Q3 | $178K | Hold |
734
| – | – | ﹤0.01% | 815 |
|
|
2021
Q2 | $174K | Hold |
734
| – | – | ﹤0.01% | 775 |
|
|
2021
Q1 | $161K | Hold |
734
| – | – | ﹤0.01% | 754 |
|
|
2020
Q4 | $128K | Hold |
734
| – | – | ﹤0.01% | 698 |
|
|
2020
Q3 | $119K | Hold |
734
| – | – | ﹤0.01% | 689 |
|
|
2020
Q2 | $105K | Sell |
734
-1,337
| -65% | -$185K | ﹤0.01% | 704 |
|
|
2020
Q1 | $224K | Buy |
2,071
+1,164
| +128% | +$168K | 0.01% | 626 |
|
|
2019
Q4 | $132K | Buy |
+907
| New | +$131K | ﹤0.01% | 731 |
|
|
2019
Q2 | – | Sell |
-1,803
| Closed | -$237K | – | 603 |
|
|
2019
Q1 | $237K | Buy |
+1,803
| New | +$222K | 0.01% | 535 |
|
|
2018
Q4 | – | Sell |
-1,964
| Closed | -$293K | – | 955 |
|
|
2018
Q3 | $293K | Sell |
1,964
-180
| -8% | -$27.4K | 0.01% | 584 |
|
|
2018
Q2 | $331K | Sell |
2,144
-764
| -26% | -$115K | 0.01% | 564 |
|
|
2018
Q1 | $404K | Sell |
2,908
-1,218
| -30% | -$179K | 0.02% | 510 |
|
|
2017
Q4 | $566K | Sell |
4,126
-807
| -16% | -$107K | 0.03% | 413 |
|
|
2017
Q3 | $640K | Buy |
+4,933
| New | +$658K | 0.04% | 405 |
|
|
2017
Q1 | – | Sell |
-815
| Closed | -$90K | – | 885 |
|
|
2016
Q4 | $90K | Buy |
+815
| New | +$90.5K | 0.01% | 675 |
|
Other funds holding LH
Ancora Advisors's LH Position: Q2 2026 in Review
Ancora Advisors reduced its Labcorp (LH) stake by 52% in Q2 2026, selling an estimated $69.9K and leaving 241 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #991.
Ancora Advisors first reported a position in LH in Q4 2016 and has held it in 34 quarters since. The position peaked at $640K in Q3 2017. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Ancora Advisors held 241 shares of Labcorp worth $67.5K as of Q2 2026.
- Ancora Advisors sold 266 Labcorp shares in Q2 2026, an estimated $69.9K.
- Labcorp made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #991 holding.
- Ancora Advisors first reported a position in Labcorp in Q4 2016 and has held it in 34 quarters since.
- Ancora Advisors's Labcorp position peaked at $640K in Q3 2017.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.